Layout:

Biotech Boom Supported with US$5.5bn from State-Owned Investors

19th November, 2021

The pandemic has fuelled investor interest in biotech, life sciences and drug discovery with state-owned investors ploughing more than US$5.5 billion into the space so far this year, mostly in the form of venture capital for startups – an increase of 53% over the whole of 2020.

Fund of the Month (Sept'21): Alaska PFC

1st September, 2021

On August 3, Alaska PFC reported its best annual performance ever, with a 29.7% return, and an all-time peak AuM of US$ 81.1 billion. A month before that, it had unveiled its strategy up to June 2025, when it expects private markets to rise to 40% of its portfolio. We had the immense pleasure of talking with Ms. Angela Rodell, who on October 1 will stand as the world’s only female CEO of a SWF.

Stocks and Bonds Boost Annual Returns, But Private Markets Drive Long-Term Growth

27th August, 2021

Recent annual returns by state-owned investors have demonstrated that the rally in public equities has boosted portfolios, but long-term returns suggest private markets generate stronger yield.

Alaska PFC returns c.30% in FY21, private markets to reach 40%

9th August, 2021

Last week, United States’ largest Sovereign Wealth Fund, the Alaska Permanent Fund Corporation (APFC) released its results for the year ending on June 30, 2021 (FY21) and gave a clue on its strategy to FY25.

Female Inclusion Survey: Gender Inequality Persists at the Top of State-Owned Investors

22nd March, 2021

State-Owned Investors have still a long way to go when it comes to diversity and inclusion.

Alpha Trains Leads Daily Deals with State-Owned Investors On-Track for Extraordinary Month

13th January, 2021

The first month of 2021 is turning out to be a bumper month for investment by state-owned investors with the volume and value of transactions set to rival the busiest months of 2020 - and potentially see the return of activity to pre-pandemic norms.

Reset filters
News by Tag:
News by Fund: